Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
Top Cited Papers
- 10 May 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (19), 1928-1943
- https://doi.org/10.1056/nejmoa061760
Abstract
A phase 3 trial was conducted to evaluate the efficacy of a prophylactic quadrivalent vaccine in preventing anogenital diseases associated with human papillomavirus (HPV) types 6, 11, 16, and 18.Keywords
This publication has 27 references indexed in Scilit:
- Vulvar Intraepithelial NeoplasiaObstetrics & Gynecology, 2005
- Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of CausalityJNCI Monographs, 2003
- Detection of human papillomavirus type 16 in bowenoid papulosis and nonbowenoid tissuesInternational Journal of Dermatology, 2003
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approachJournal of Medical Virology, 2001
- PATHOGENESIS AND TREATMENT OF JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSISOtolaryngologic Clinics of North America, 2000
- Primary Vaginal CancerSurgical Oncology Clinics of North America, 1998
- Trends in Squamous Cell Carcinoma of the Vulva: The Influence of Vulvar Intraepithelial NeoplasiaPublished by Wolters Kluwer Health ,1998
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997
- Partial characterization of viral DNA from human genital warts (condylomata acuminata)International Journal of Cancer, 1980